Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Oncology Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1021-335X Online ISSN: 1791-2431
Journal Cover
February-2025 Volume 53 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
February-2025 Volume 53 Issue 2

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML

  • Supplementary Files
    • Supplementary_Data.pdf
Article Open Access

SPRR1A is a potential therapeutic target for osteosarcoma: in vitro and in vivo evaluations using generated artificial osteosarcoma cancer stem cell‑like cells

  • Authors:
    • Tomohiro Miyamoto
    • Naomasa Fukase
    • Teruya Kawamoto
    • Shuichi Fujiwara
    • Hitomi Hara
    • Ryoko Sawada
    • Yuta Nakamatsu
    • Yutaka Mifune
    • Kenichiro Kakutani
    • Yuichi Hoshino
    • Shinya Hayashi
    • Tomoyuki Matsumoto
    • Takehiko Matsushita
    • Michiyo Koyanagi‑Aoi
    • Takashi Aoi
    • Toshiyuki Takemori
    • Shunsuke Yahiro
    • Ryosuke Kuroda
    • Toshihiro Akisue
  • View Affiliations / Copyright

    Affiliations: Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe 650‑0017, Japan, Department of Orthopaedic Surgery, Konan Medical Center, 658‑0064 Kobe, Japan, Division of Stem Cell Medicine, Kobe University Graduate School of Medicine, Kobe 650‑0017, Japan, Department of Orthopaedic Surgery, Hyogo Cancer Center, Akashi 673‑8558, Japan
    Copyright: © Miyamoto et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Article Number: 24
    |
    Published online on: December 16, 2024
       https://doi.org/10.3892/or.2024.8857
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Cancer stem cells (CSCs) have been implicated as critical mediators in the progression, chemoresistance and metastatic capabilities of diverse malignancies, including osteosarcoma (OS). The authors have succeeded in generating CSC‑like cells (MG‑OKS) from the OS cell line MG‑63 by transducing defined factors. A significant increase in small proline‑rich protein 1A (SPRR1A) expression, a cross‑linked envelope protein in keratinocytes, was observed in MG‑OKS cells. Therefore, SPRR1A could be involved in tumor initiation, growth and poor OS progression. However, its specific role in OS remains unclear. The present study aimed to evaluate the role of SPRR1A in OS both in vitro and in vivo using MG‑OKS cells. Three experimental groups were established: MG‑OKS cells transfected with SPRR1A small interfering (si)RNA (siMG‑OKS), untransfected MG‑OKS cells and MG‑OKS cells transfected with scrambled siRNA (scMG‑OKS) as controls. SPRR1A expression, morphological changes, cell proliferation and migration were assessed in these groups. RNA sequencing was performed to examine the genetic changes caused by SPRR1A suppression. To evaluate tumorigenicity in vivo, cells from each group were subcutaneously transplanted into the backs of nude mice. Tumor volume and Ki‑67 expression were assessed and compared among the three groups at four weeks post‑transplantation. The siMG‑OKS group exhibited altered cell morphology, reduced cell proliferation and decreased migratory abilities in vitro. RNA sequencing revealed suppression of genes involved in cell adhesion in the siMG‑OKS group. Furthermore, the in vivo tumorigenicity of siMG‑OKS was lower than that of the other two experimental groups. These findings suggest that SPRR1A is one of the key cell adhesion‑related molecules involved in OS progression, potentially serving as a therapeutic target for this refractory tumor. However, further research is needed to fully elucidate the mechanisms by which SPRR1A influences OS pathogenesis and to explore its clinical potential.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

View References

1 

Wittig JC, Bickels J, Priebat D, Jelinek J, Kellar-Graney K, Shmookler B and Malawer MM: Osteosarcoma: A multidisciplinary approach to diagnosis and treatment. Am Fam Physician. 65:1123–1132. 2002.PubMed/NCBI

2 

Odri GA, Tchicaya-Bouanga J, Yoon DJY and Modrowski D: Metastatic progression of osteosarcomas: A review of current knowledge of environmental versus oncogenic drivers. Cancers (Basel). 14:3602022. View Article : Google Scholar : PubMed/NCBI

3 

Zhao X, Wu Q, Gong X, Liu J and Ma Y: Osteosarcoma: A review of current and future therapeutic approaches. Biomed Eng Online. 20:242021. View Article : Google Scholar : PubMed/NCBI

4 

Shiozawa Y, Nie B, Pienta KJ, Morgan TM and Taichman RS: Cancer stem cells and their role in metastasis. Pharmacol Ther. 138:285–293. 2013. View Article : Google Scholar : PubMed/NCBI

5 

He H, Ni J and Huang J: Molecular mechanisms of chemoresistance in osteosarcoma (review). Oncol Lett. 7:1352–1362. 2014. View Article : Google Scholar : PubMed/NCBI

6 

Abarrategi A, Tornin J, Martinez-Cruzado L, Hamilton A, Martinez-Campos E, Rodrigo JP, González MV, Baldini N, Garcia-Castro J and Rodriguez R: Osteosarcoma: Cells-of-origin, cancer stem cells, and targeted therapies. Stem Cells Int. 2016:36317642016. View Article : Google Scholar : PubMed/NCBI

7 

Oshima N, Yamada Y, Nagayama S, Kawada K, Hasegawa S, Okabe H, Sakai Y and Aoi T: Induction of cancer stem cell properties in colon cancer cells by defined factors. PLoS One. 9:e1017352014. View Article : Google Scholar : PubMed/NCBI

8 

Fujiwara S, Kawamoto T, Kawakami Y, Koterazawa Y, Hara H, Takemori T, Kitayama K, Yahiro S, Kakutani K, Matsumoto T, et al: Acquisition of cancer stem cell properties in osteosarcoma cells by defined factors. Stem Cell Res Ther. 11:4292020. View Article : Google Scholar : PubMed/NCBI

9 

Steinert PM, Candi E, Kartasova T and Marekov L: Small proline-rich proteins are cross-bridging proteins in the cornified cell envelopes of stratified squamous epithelia. J Struct Biol. 122:76–85. 1998. View Article : Google Scholar : PubMed/NCBI

10 

Yamakawa K, Koyanagi-Aoi M, Uehara K, Masuda A, Yanagimoto H, Toyama H, Fukumoto T, Kodama Y and Aoi T: Increased expression of SPRR1A is associated with a poor prognosis in pancreatic ductal adenocarcinoma. PLoS One. 17:e02666202022. View Article : Google Scholar : PubMed/NCBI

11 

Candi E, Schmidt R and Melino G: The cornified envelope: A model of cell death in the skin. Nat Rev Mol Cell Biol. 6:328–340. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Deng Y, Zheng X, Zhang Y, Xu M, Ye C, Lin M, Pan J, Xu Z, Lu X and Chi P: High SPRR1A expression is associated with poor survival in patients with colon cancer. Oncol Lett. 19:3417–3424. 2020.PubMed/NCBI

13 

Zhang H, Gao J, Zhao Z, Li M and Liu C: Clinical implications of SPRR1A expression in diffuse large B-cell lymphomas: A prospective, observational study. BMC Cancer. 14:3332014. View Article : Google Scholar : PubMed/NCBI

14 

Zhang Z, Tu K, Liu F, Liang M, Yu K, Wang Y, Luo Y, Yang B, Qin Y, He D, et al: FoxM1 promotes the migration of ovarian cancer cell through KRT5 and KRT7. Gene. 757:1449472020. View Article : Google Scholar : PubMed/NCBI

15 

Hu J, Zhang LC, Song X, Lu JR and Jin Z: KRT6 interacting with notch1 contributes to progression of renal cell carcinoma, and aliskiren inhibits renal carcinoma cell lines proliferation in vitro. Int J Clin Exp Pathol. 8:9182–9188. 2015.PubMed/NCBI

16 

Li Q, Yin L, Jones LW, Chu GCY, Wu JBY, Huang JM, Li Q, You S, Kim J, Lu YT, et al: Keratin 13 expression reprograms bone and brain metastases of human prostate cancer cells. Oncotarget. 7:84645–84657. 2016. View Article : Google Scholar : PubMed/NCBI

17 

Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K and Yamanaka S: Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 131:861–872. 2007. View Article : Google Scholar : PubMed/NCBI

18 

Ishida R, Koyanagi-Aoi M, Oshima N, Kakeji Y and Aoi T: The tissue-reconstructing ability of colon CSCs is enhanced by FK506 and suppressed by GSK3 inhibition. Mol Cancer Res. 15:1455–1466. 2017. View Article : Google Scholar : PubMed/NCBI

19 

Ogawa H, Koyanagi-Aoi M, Otani K, Zen Y, Maniwa Y and Aoi T: Interleukin-6 blockade attenuates lung cancer tissue construction integrated by cancer stem cells. Sci Rep. 7:123172017. View Article : Google Scholar : PubMed/NCBI

20 

Salaria S, Means A, Revetta F, Idrees K, Liu E and Shi C: Expression of CD24, a stem cell marker, in pancreatic and small intestinal neuroendocrine tumors. Am J Clin Pathol. 144:642–648. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Wu C, Xie Y, Gao F, Wang Y, Guo Y, Tian H, Li Y and Fan W: Lgr5 expression as stem cell marker in human gastric gland and its relatedness with other putative cancer stem cell markers. Gene. 525:18–25. 2013. View Article : Google Scholar : PubMed/NCBI

22 

Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI

23 

Xie Y, Sun W, Deng Z, Zhu X, Hu C and Cai L: MiR-302b suppresses osteosarcoma cell migration and invasion by targeting Runx2. Sci Rep. 7:133882017. View Article : Google Scholar : PubMed/NCBI

24 

Cheadle C, Vawter MP, Freed WJ and Becker KG: Analysis of microarray data using Z score transformation. J Mol Diagn. 5:73–81. 2003. View Article : Google Scholar : PubMed/NCBI

25 

Cidado J, Wong HY, Rosen DM, Cimino-Mathews A, Garay JP, Fessler AG, Rasheed ZA, Hicks J, Cochran RL, Croessmann S, et al: Ki-67 is required for maintenance of cancer stem cells but not cell proliferation. Oncotarget. 7:6281–6293. 2016. View Article : Google Scholar : PubMed/NCBI

26 

Zeng M, Zhou J, Wen L, Zhu Y, Luo Y and Wang W: The relationship between the expression of Ki-67 and the prognosis of osteosarcoma. BMC Cancer. 21:2102021. View Article : Google Scholar : PubMed/NCBI

27 

Chaudhary RK, Patil P, Shetty VV, Ananthesh L, Kalladka SS, Mateti UV and Raju B: Decoding the role of SPRR1A and SPRR1B gene in cancer: A comprehensive review. Gene Rep. 36:1019262024. View Article : Google Scholar

28 

Yu H, Gao M, Ma Y, Wang L, Yang S and Liu X: Inhibition of cell migration by focal adhesion kinase: Time-dependent difference in integrin-induced signaling between endothelial and hepatoblastoma cells. Int J Mol Med. 41:2573–2588. 2018.PubMed/NCBI

29 

Maziveyi M, Dong S, Baranwal S and Alahari SK: Nischarin regulates focal adhesion and Invadopodia formation in breast cancer cells. Mol Cancer. 17:212018. View Article : Google Scholar : PubMed/NCBI

30 

Benaud CM and Dickson RB: Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc. Oncogene. 20:4554–4567. 2001. View Article : Google Scholar : PubMed/NCBI

31 

Gao D, Inuzuka H, Tseng A, Chin RY, Toker A and Wei W: Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat Cell Biol. 11:397–408. 2009. View Article : Google Scholar : PubMed/NCBI

32 

Walker JL, Fournier AK and Assoian RK: Regulation of growth factor signaling and cell cycle progression by cell adhesion and adhesion-dependent changes in cellular tension. Cytokine Growth Factor Rev. 16:395–405. 2005. View Article : Google Scholar : PubMed/NCBI

33 

Kim GD: Induction of hepatocellular carcinoma cell cycle arrest and apoptosis by dendropanax morbifera leveille leaf extract via the PI3K/AKT/mTOR pathwayc. J Cancer Prev. 28:185–193. 2023. View Article : Google Scholar : PubMed/NCBI

34 

Ball KL, Lain S, Fâhraeus R, Smythe C and Lane DP: Cell-cycle arrest and inhibition of Cdk4 activity by small peptides based on the carboxy-terminal domain of p21WAF1. Curr Biol. 7:71–80. 1997. View Article : Google Scholar : PubMed/NCBI

35 

Chen Y, Liu J, Zhou B, Yang M and Feng H: The value of Ki-67 as a prognostic biomarker in osteosarcoma: A systematic review and meta-analysis. Asian J Surg. 45:2978–2980. 2022. View Article : Google Scholar : PubMed/NCBI

36 

Kovac M, Blattmann C, Ribi S, Smida J, Mueller NS, Engert F, Castro-Giner F, Weischenfeldt J, Kovacova M, Krieg A, et al: Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency. Nat Commun. 6:89402015. View Article : Google Scholar : PubMed/NCBI

37 

Rajan S, Franz EM, McAloney CA, Vetter TA, Cam M, Gross AC, Taslim C, Wang M, Cannon MV, Oles A and Roberts RD: Osteosarcoma tumors maintain intra-tumoral transcriptional heterogeneity during bone and lung colonization. BMC Biol. 21:982023. View Article : Google Scholar : PubMed/NCBI

38 

Brown HK, Tellez-Gabriel M and Heymann D: Cancer stem cells in osteosarcoma. Cancer Lett. 386:189–195. 2017. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Miyamoto T, Fukase N, Kawamoto T, Fujiwara S, Hara H, Sawada R, Nakamatsu Y, Mifune Y, Kakutani K, Hoshino Y, Hoshino Y, et al: <em>SPRR1A</em> is a potential therapeutic target for osteosarcoma: <em>in vitro</em> and <em>in vivo</em> evaluations using generated artificial osteosarcoma cancer stem cell‑like cells. Oncol Rep 53: 24, 2025.
APA
Miyamoto, T., Fukase, N., Kawamoto, T., Fujiwara, S., Hara, H., Sawada, R. ... Akisue, T. (2025). <em>SPRR1A</em> is a potential therapeutic target for osteosarcoma: <em>in vitro</em> and <em>in vivo</em> evaluations using generated artificial osteosarcoma cancer stem cell‑like cells. Oncology Reports, 53, 24. https://doi.org/10.3892/or.2024.8857
MLA
Miyamoto, T., Fukase, N., Kawamoto, T., Fujiwara, S., Hara, H., Sawada, R., Nakamatsu, Y., Mifune, Y., Kakutani, K., Hoshino, Y., Hayashi, S., Matsumoto, T., Matsushita, T., Koyanagi‑Aoi, M., Aoi, T., Takemori, T., Yahiro, S., Kuroda, R., Akisue, T."<em>SPRR1A</em> is a potential therapeutic target for osteosarcoma: <em>in vitro</em> and <em>in vivo</em> evaluations using generated artificial osteosarcoma cancer stem cell‑like cells". Oncology Reports 53.2 (2025): 24.
Chicago
Miyamoto, T., Fukase, N., Kawamoto, T., Fujiwara, S., Hara, H., Sawada, R., Nakamatsu, Y., Mifune, Y., Kakutani, K., Hoshino, Y., Hayashi, S., Matsumoto, T., Matsushita, T., Koyanagi‑Aoi, M., Aoi, T., Takemori, T., Yahiro, S., Kuroda, R., Akisue, T."<em>SPRR1A</em> is a potential therapeutic target for osteosarcoma: <em>in vitro</em> and <em>in vivo</em> evaluations using generated artificial osteosarcoma cancer stem cell‑like cells". Oncology Reports 53, no. 2 (2025): 24. https://doi.org/10.3892/or.2024.8857
Copy and paste a formatted citation
x
Spandidos Publications style
Miyamoto T, Fukase N, Kawamoto T, Fujiwara S, Hara H, Sawada R, Nakamatsu Y, Mifune Y, Kakutani K, Hoshino Y, Hoshino Y, et al: <em>SPRR1A</em> is a potential therapeutic target for osteosarcoma: <em>in vitro</em> and <em>in vivo</em> evaluations using generated artificial osteosarcoma cancer stem cell‑like cells. Oncol Rep 53: 24, 2025.
APA
Miyamoto, T., Fukase, N., Kawamoto, T., Fujiwara, S., Hara, H., Sawada, R. ... Akisue, T. (2025). <em>SPRR1A</em> is a potential therapeutic target for osteosarcoma: <em>in vitro</em> and <em>in vivo</em> evaluations using generated artificial osteosarcoma cancer stem cell‑like cells. Oncology Reports, 53, 24. https://doi.org/10.3892/or.2024.8857
MLA
Miyamoto, T., Fukase, N., Kawamoto, T., Fujiwara, S., Hara, H., Sawada, R., Nakamatsu, Y., Mifune, Y., Kakutani, K., Hoshino, Y., Hayashi, S., Matsumoto, T., Matsushita, T., Koyanagi‑Aoi, M., Aoi, T., Takemori, T., Yahiro, S., Kuroda, R., Akisue, T."<em>SPRR1A</em> is a potential therapeutic target for osteosarcoma: <em>in vitro</em> and <em>in vivo</em> evaluations using generated artificial osteosarcoma cancer stem cell‑like cells". Oncology Reports 53.2 (2025): 24.
Chicago
Miyamoto, T., Fukase, N., Kawamoto, T., Fujiwara, S., Hara, H., Sawada, R., Nakamatsu, Y., Mifune, Y., Kakutani, K., Hoshino, Y., Hayashi, S., Matsumoto, T., Matsushita, T., Koyanagi‑Aoi, M., Aoi, T., Takemori, T., Yahiro, S., Kuroda, R., Akisue, T."<em>SPRR1A</em> is a potential therapeutic target for osteosarcoma: <em>in vitro</em> and <em>in vivo</em> evaluations using generated artificial osteosarcoma cancer stem cell‑like cells". Oncology Reports 53, no. 2 (2025): 24. https://doi.org/10.3892/or.2024.8857
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team